| 65.46 Data as of May 17 |  +1.30 / +2.03%Today’s Change | 30.51 Today|||52-Week Range 65.89 | +98.79% Year-to-Date |
| Why the Street Should Love USANA Health Sciences's Earnings May 14 / MotleyFool.com |
| Previous close | 64.16 |
| Today’s open | 64.20 |
| Day’s range | 64.20 - 65.89 |
| Volume | 56,083 |
| Average volume (3 months) | 122,480 |
| Market cap | $882.7M |
| Dividend yield | -- |
| Earnings growth (last year) | +36.50% |
| Earnings growth (this year) | +21.03% |
| Earnings growth (next 5 years) | +18.00% |
| Revenue growth (last year) | +11.48% |
| P/E ratio | 13.6 |
| Price/Sales | 0.71 |
| Price/Book | 4.88 |
| Today’s change | Today’s % change | |
|---|---|---|
| CLVSClovis Oncology Inc | +0.18 | +0.49% |
| NBIXNeurocrine Bioscienc... | -0.24 | -2.00% |
| ACHNAchillion Pharmaceut... | +0.21 | +2.78% |
| AUXLAuxilium Pharmaceuti... | -0.04 | -0.27% |
| Next reporting date | July 23, 2013 |
| EPS forecast (this quarter) | $1.33 |
| Annual revenue (last year) | $648.7M |
| Annual profit (last year) | $66.4M |
| Net profit margin | 10.24% |
Sector Consumer Non-Durables |
Industry Household/Personal Care |
Chairman Myron W. Wentz, PhD |
Chief Executive Officer David A. Wentz |
Corporate headquarters Salt Lake City, Utah |
.
